Trump’s pick for open House seat in Kentucky scrubs president from campaign website
President Trump’s pick to replace Republican Rep. Andy Barr (Ky.) in the House has completely scrubbed the president from his campaign website. Former state Sen. Ralph Alvarado’s (R) campaign website no longer features an image of the candidate next to Trump with them both giving.
Expanded Context
Brimstone Report is tracking this as a curated politics brief. The source report from The Hill says: President Trump’s pick to replace Republican Rep. Andy Barr (Ky.) in the House has completely scrubbed the president from his campaign website. Former state Sen. Ralph Alvarado’s (R) campaign website no longer features an image of the candidate next to Trump with them both giving.
This page is not original reporting. It gives readers the Brimstone view of the story: what is known from the attributed source, why the topic matters, and where to continue reading the original report.
At publication, this brief is anchored to a single attributed source. Readers should treat early details as provisional until additional reporting, official statements, or documents appear.
Why It Matters
Political developments can affect public policy, agencies, budgets, investigations, elections, and the legal process. The value is in tracking what changed and what remains unresolved.
Key Facts
- Primary source: The Hill
- Published: Aug 25, 2026, 10:59 PM UTC
- Coverage area: Politics
- Brimstone role: curated summary, explanation, and source attribution
- Topic signals: developing story metadata
Timeline
- Source published: Aug 25, 2026, 10:59 PM UTC
- Brimstone indexed: Added to the curated Brimstone feed and linked to related coverage.
- Next update to watch: Additional sourcing, official confirmation, court or agency records, or follow-up reporting.
Source Attribution
This Brimstone page summarizes and contextualizes a third-party report. Continue to the original publisher for full reporting, documents, quotes, and updates.
Read Original SourceRelated Stories
Trump’s FDA nominee could renew scrutiny to abortion drug risk: pro-life org CEO
